Gilead Sciences, Inc. (NASDAQ: GILD) has had a considerably better year than the broader market. The stock has surged by over ...
Johnson & Johnson’s 44% one-year gain has pushed its valuation higher, but expanding growth drivers across pharmaceuticals ...
Pfizer Inc. (NYSE:PFE) has barely rewarded shareholders over the past year. That underperformance has left Pfizer looking ...
Nova Ltd. (NASDAQ:NVMI) grew second-quarter revenue 15.9%, but diluted GAAP earnings per share increased only 2.8%.
KLA Corporation (NASDAQ:KLAC) returned $876.3 million to shareholders in its fiscal fourth quarter while generating $817.1 ...
Lam Research Corporation (NASDAQ:LRCX) reported $2.472 billion of customer support-related and other revenue in its June ...
T. Rowe Price Group, Inc. (NASDAQ:TROW) is an active investment manager that earns most of its revenue from management fees, ...
ABM Industries Incorporated (NYSE:ABM) isn’t the kind of stock that makes headlines, but for income-focused investors, it ...
Despite these challenges, PepsiCo, Inc. bumped its dividend again in 2026 by 4% to $5.92 per share. That marks 54 years in a ...
The Coca-Cola Company (NYSE: KO) is a fixture in many dividend portfolios, and for good reason. Its lineup of household names ...
Parker-Hannifin Corporation (NYSE:PH) has established an extensive history of increasing its dividend by providing products ...
Abbott Laboratories (NYSE:ABT) offers investors access to several segments of the healthcare industry, including diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results